Related Experiment Video
Updated: Jul 5, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
The Systemic Immune-Inflammation Index (SII) and coronary artery lesions in Kawasaki disease
Tiantuo Huang1, Qi Peng1, Yiyue Zhang1
1Department of Pediatrics, The First Affiliated Hospital of Anhui Medical University, No.218 Ji-Xi Road, Hefei, Anhui Province, China.
Insights
The Systemic Immune-Inflammation Index (SII) is a significant risk factor for coronary artery lesions (CALs) in children with Kawasaki disease (KD). This index can aid in the early prediction of CALs, improving patient prognosis.
Area of Science:
- Pediatric Cardiology
- Inflammatory Diseases
- Biomarker Discovery
Background:
- Coronary artery lesions (CALs) are a major complication of Kawasaki disease (KD), impacting long-term prognosis.
- Early identification of children at risk for CALs is crucial for timely intervention and management.
- The Systemic Immune-Inflammation Index (SII) has emerged as a potential indicator of systemic inflammation.
Purpose of the Study:
- To investigate the association between the Systemic Immune-Inflammation Index (SII) and the presence of coronary artery lesions (CALs) in pediatric patients diagnosed with Kawasaki disease (KD).
- To evaluate the predictive value of SII for the development of CALs at the time of admission in KD patients.
Main Methods:
- Retrospective analysis of medical records from 364 KD patients treated between January 2017 and January 2023.
- Statistical analyses included single-variable tests, binary logistic regression, ROC curve analysis, and restricted cubic spline tests.
- Evaluation of the relationship between SII levels and the occurrence of CALs at admission.
Main Results:
- Of the 364 patients, 63 (17.3%) had CALs upon admission.
- Binary logistic regression confirmed SII as a significant risk factor for CALs, both unadjusted and adjusted for confounders.
- ROC curve analysis showed an AUC of 0.789 for SII in predicting CALs at admission (P < 0.001).
- A positive linear relationship was observed between SII and the risk of CALs.
Conclusions:
- The Systemic Immune-Inflammation Index (SII) is a significant risk factor for coronary artery lesions (CALs) in patients with Kawasaki disease (KD).
- SII demonstrates utility as an auxiliary laboratory biomarker for the early prediction of CALs in KD.
- These findings support the integration of SII assessment in the initial evaluation of KD patients to identify those at higher risk for coronary complications.
Abstract:
Coronary artery lesions (CALs) are the most common complications of Kawasaki disease (KD) and play a crucial role in determining the prognosis of the disease. Consequently, the early identification of children with KD who are at risk of developing coronary artery damage is vitally important. We sought to investigate the relationship between the Systemic Immune-Inflammation Index (SII) and CALs in patients with KD and to assess its predictive value. We carried out a retrospective review and analysis of medical records for KD patients treated at the First Affiliated Hospital of Anhui Medical University between January 2017 and January 2023. We utilized single-variable tests, binary logistic regression analysis, ROC curve analysis, restricted cubic spline tests, and curve fitting to evaluate the association between SII and CALs. In our study, 364 patients were included, with 63 (17.3%) presenting with CALs at the time of admission. The binary logistic regression analysis indicated that SII was a significant risk factor for CALs at admission, evident in both unadjusted and models adjusted for confounders. The ROC curve analysis revealed an AUC (Area Under the Curve) value of 0.789 (95%CI 0.723-0.855, P < 0.001) for SII's predictive ability regarding CALs at admission. A consistent positive linear relationship between SII and the risk of CALs at admission was observed in both the raw and adjusted models. Our research findings suggest that SII serves as a risk factor for CALs and can be used as an auxiliary laboratory biomarker for predicting CALs.

